Lionheart Gets €2.2 Billion Backing as Vulcan Management Scoops Up More Shares

Vulcan Energy closes €2.2 billion financing for Lionheart lithium project; stock falls 6% as insiders convert performance rights to shares. Project targets 24,000 tonnes annual output by 2028.

Vulcan Energy has secured the full financing package for its flagship Lionheart project in the Upper Rhine Valley, a €2.2 billion deal that brings together a consortium of commercial banks alongside European and German public authorities. The European Investment Bank alone is chipping in €250 million. Yet investors delivered a lukewarm response: the shares tanked more than 6% on the day of the announcement, closing at €2.20, well below the 200-day moving average of €2.61.

At the same time, the company’s top brass has been quietly adding to their holdings — not through open-market purchases, but by converting earned performance rights into ordinary equity. Managing director Francis Wedin received roughly 10,000 new shares as part of the regular compensation structure. His total stake now exceeds 16.4 million shares. Director Günter Hilken picked up about 4,700 shares, bringing his holdings to just over 19,000. The conversion was calculated at A$4.00 per share.

The insider accumulation comes during a tough stretch for the stock. Vulcan’s shares have lost around 45% from their 2024 peak and are down more than 15% year-to-date. Over the past seven days alone, they shed roughly 7%. The volatility gauge sits at around 70%, underscoring jittery investor sentiment. With the 50-day line at €2.16, a break below that short-term support could open the door to the year’s low of €1.77.

Operationally, the company is pushing ahead with Lionheart, a project designed to produce 24,000 tonnes of battery-grade lithium hydroxide per year — enough to equip half a million electric vehicles. Unlike conventional mining, Vulcan extracts lithium from hot geothermal brine, a process that requires less land and far less water. Construction is already under way in Frankfurt on a central chemical plant that will convert pumped lithium chloride into hydroxide via electrolysis. The build-out phase is slated to last about two-and-a-half years, with commercial production due in 2028.

Once operational, Lionheart should cover roughly 12% of Europe’s lithium hydroxide needs, a strategically important contribution as the continent races to secure critical raw materials. The deep geothermal wells will also deliver renewable electricity and heat. For now, however, the market is keeping its distance. The shares remain trapped beneath long-term trendlines, and management still has to prove it can execute the ambitious construction timetable without cost overruns.